About making a CHO production cell line "research-friendly" by genetic engineering

BMC Proc. 2011 Nov 22;5 Suppl 8(Suppl 8):P132. doi: 10.1186/1753-6561-5-S8-P132. eCollection 2011.

Authors

Bernd Voedisch¹, Agnès Patoux¹, Jildou Sterkenburgh², Mirjam Buchs¹, Emily Barry³, Cyril Allard¹, Sabine Geisse¹

Affiliations

¹ Novartis Pharma AG, Basel, Switzerland.
² University of Cambridge, Cambridge, United Kingdom.
³ Cardiff University, Cardiff, United Kingdom.

No abstract available